Albiglutide
A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.
GSK · Phase 3 · Completed · Enrollment 507
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| albiglutide | n/r | n/r | n/r | n/r | n/r |
| sitagliptin | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.